Mona Hamdy

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Sickle Cell Disease

Peritoneal Dialysis

Ejection Fraction

Top Venues

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Mona Hamdy, Iman A Shaheen, Mohamed Khallaf, Yasmeen M M Selim
Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity. Pediatric blood & cancer 71 (6) (2024)
Mona Hamdy, Iman A Shaheen, Mohamed Khallaf, Yasmeen M M Selim
Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity. Pediatric blood & cancer 71 (6) (2024)
Mona Hamdy, Iman A Shaheen, Mohamed Khallaf, Yasmeen M M Selim
Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity. Pediatric blood & cancer 71 (6) (2024)
Mona Hamdy, Iman A Shaheen, Mohamed Khallaf, Yasmeen M M Selim
Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity. Pediatric blood & cancer (2024)
Mona Hamdy, Amal El-Beshlawy, Mônica P A Veríssimo, Julie Kanter, Baba Psalm Duniya Inusa, Suzan Williams, David Lee, Noemi Toiber Temin, Caroline Fradette, Fernando Tricta, Fatma Soliman Elsayed Ebeid, Janet L Kwiatkowski, Mohsen S Elalfy
Deferiprone versus deferoxamine for transfusional iron overload in sickle cell disease and other anemias: Pediatric subgroup analysis of the randomized, open-label FIRST study. Pediatric blood & cancer (2023)